[The use of a somatostatin analog (Sandostatin) in percutaneous drainage of pancreatic pseudocysts].
The inflammatory pancreatic diseases are usually hardly governable; special problems are arosen with the treatment of pancreatic fluid collections. The focal pericystic pancreatitis, the reactive inflammation developing in the course of the injury of the gland as well as draining pancreatic duct filling the cyst up may result in pitfalls. Thus subcutaneous administration of Sandostatin was added to the usual therapeutic regimen in 12 patients. It was applied with external and internal drainage of pseudocysts in 10 patients and in one of them the complication was reduced in an unsuccessful attempt, respectively. The pseudocyst of one patient disappeared by sole somatostatin administration. One cystic formation did not respond to this kind of treatment thus a drainage procedure had to be performed. Based on our initial experiences we seem to find a rather promising tool that may influence the basic process beneficially and makes our instrumental interventions safer and more successful.
Mádi Szabó
L
L
Gasztroenterológiai Ultraszonográfiás Részleg, Pest megyei Budagyöngye Kórház, Budapest.
Pásztor
J
J
D000328:Adult; D000437:Alcoholism / Q000150:complications; D004322:Drainage; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D010192:Pancreatic Pseudocyst / Q000209:etiology / Q000628:therapy*; D010195:Pancreatitis / Q000150:complications / Q000209:etiology
D015282:Octreotide
Somatostatin analog (Sandostatin) alkalmazása pancreas pseudocysták percutan katéteres kezelésében.